Connected monitors, infusion pumps, imaging gateways, and patient-at-home sensors only work if they stay available, trustworthy, and clinically safe. That is why IoMT security is not a niche IT problem; it is a mix of device hardening, network design, procurement discipline, and incident response. In the UK, the stakes are higher still because these systems often sit inside regulated care pathways and support long-lived clinical workflows.
The essentials for securing connected medical devices and networks
- The main risk is not just data theft; it is disruption to care and patient safety.
- Secure updates, strong authentication, encryption, and interface control are the first layer.
- Network segmentation matters because one weak device should not become a hospital-wide problem.
- Patch timing, support lifetimes, and vendor responsibilities must be decided before deployment.
- Logging, alerting, and response playbooks determine how fast you can contain an incident.
- UK teams should align cyber controls with MHRA expectations, NHS guidance, and local clinical safety processes.
Why connected medical devices need a different security model
I treat connected medical devices differently from ordinary endpoints. A compromise can expose data, but it can also delay treatment, corrupt readings, or create a downtime event that matters clinically. NHS England is clear that incidents affecting connected devices can disrupt care and put patients at risk, and updates may need careful validation before deployment.
That changes the security model in three practical ways. First, availability matters as much as confidentiality. Second, patching is slower because a fix on a bedside device may need supplier testing, clinical sign-off, and a maintenance window. Third, ownership is shared: the manufacturer, the integrator, the hospital, and sometimes the home patient all hold part of the risk.
When I explain this to teams, I keep it simple: a laptop can often be reimaged after a bad day; a medical device usually cannot be handled that casually. Once that distinction is clear, the controls below make a lot more sense.
The device controls that actually move the risk
The NCSC’s device principles are a good reality check because they focus on the basics that stop most avoidable failures. I use them as a practical lens for connected clinical kit, then ask whether the vendor can prove each control, not just claim it in a brochure.
| Control | Why it matters | What I verify |
|---|---|---|
| Secure update path | Prevents tampered firmware and reduces exposure to known flaws | Signed updates, rollback support, and a realistic patch process |
| Strong authentication | Stops shared passwords and unauthorised administration | Unique accounts, MFA on the management path, and no default credentials left in place |
| Encryption in transit and at rest | Protects patient data and device telemetry from snooping or tampering | TLS or equivalent transport protection, disk encryption where feasible, and proper key handling |
| Trusted boot and integrity checks | Makes persistent malware and firmware tampering harder to hide | Secure boot, integrity validation, and tamper evidence or alerts |
| Interface control | Reduces accidental exposure through USB, Bluetooth, debug ports, or unused radios | Unused interfaces disabled, physical access rules defined, and vendor service ports restricted |
| Logging and health telemetry | Gives defenders a chance to notice compromise or failure early | Exportable logs, time synchronisation, and alerts that reach a central platform |
If a device cannot support one of these controls natively, I want an equivalent control around it. That can mean a gateway, a tightly controlled management host, or a network boundary that compensates for the weakness. The next layer is making sure the network itself does not turn a device problem into a service problem.
How to segment the network without breaking clinical workflows
Segmentation is not about isolating everything until nobody can use it. It is about controlling which systems can talk to which other systems, and under what conditions. The NCSC describes network segmentation as breaking a network into smaller networks so you can control traffic flows and access, and that is exactly the right mindset for medical environments.In practice, I prefer a few hard rules:
- Put clinical devices in dedicated zones or VLANs instead of leaving them on the general user network.
- Separate device management traffic from patient data traffic wherever the platform allows it.
- Allow only known destinations and ports, rather than broad internal access.
- Route vendor support through a jump host or bastion with MFA and session logging.
- Monitor east-west traffic between clinical subnets so lateral movement is visible.
- Treat patient-at-home devices as part of the same risk model, because the home network is outside your control.
The biggest mistake I see is trusting a device just because it sits inside the hospital perimeter. That assumption is too weak for a connected clinical environment, especially when remote support, wireless links, and virtual wards are involved. Once the blast radius is constrained, lifecycle support becomes the next risk to manage.
Patch management and lifecycle support are where good intentions fail
Patch management in healthcare is slow for a reason: the device may have to be validated against clinical workflows before a fix can go live. NHS England notes that security updates on connected devices can take up to three months to assess and deploy, which is why patching has to be a dedicated process rather than an ad hoc IT task.
I like to separate the lifecycle questions into four buckets:
- Support horizon - How long will the manufacturer support the device, and what happens after that date?
- Patch path - Are updates signed, tested, and recoverable if something goes wrong?
- Visibility - Can you tell which firmware, software, and component versions are installed right now?
- Dependency mapping - Do you have a software bill of materials, which is basically an ingredient list for the software stack?
That last point matters more than many teams expect. An SBOM makes vulnerability triage faster when a common library or embedded component is exposed. It does not prevent a flaw on its own, but it cuts down the time spent guessing what is actually inside the device.
The UK direction of travel is also clear: cybersecurity is being treated as a shared responsibility across manufacturers, system providers, and local deployers, not as a one-off checkbox. If a team keeps unsupported devices in service because replacement is inconvenient, I see that as a governance failure, not a technical one. Even then, failures still happen, which is why monitoring and response matter.Monitoring and incident response when a device misbehaves
Security logging, alerting, and monitoring are not optional extras in a clinical environment. They are the difference between noticing a problem early and finding out about it after the service desk is flooded or the device is already affecting care. I want logs from the device itself where possible, but if that is not available, I expect the network, gateway, or support host to provide enough visibility to compensate.
The signals I care about most are boring in the best possible way:
- Repeated authentication failures or unexpected account use.
- Sudden configuration changes outside the maintenance window.
- Unusual outbound traffic, especially to unknown addresses or countries.
- Firmware or software versions that do not match the approved baseline.
- Service degradation that lines up with a recent change or login event.
An incident playbook should answer practical questions before the incident happens: who can isolate the device, who tells clinical staff, which fallback process keeps treatment going, how evidence is preserved, and when the vendor is brought in. I also prefer tabletop exercises that include clinical engineering and ward staff, not just security teams. With that operational discipline in place, procurement and governance stop being paperwork and become risk control.
What UK teams should line up before procurement or deployment
For UK buyers, the procurement conversation matters as much as the technical one. In 2026, the regulatory and assurance direction is still moving toward lifecycle cyber accountability, with MHRA and NHS guidance pushing teams to think about security, safety, and shared responsibility together. That is especially relevant for virtual wards, home monitoring kits, and other care models that extend beyond the hospital perimeter.
Before I approve a device or service, I ask for clear answers to these questions:
- Who owns patching, and how quickly must critical vulnerabilities be addressed?
- How long is the support commitment, and what is the end-of-life plan?
- What authentication, encryption, and logging features are built in by default?
- How is vendor remote access controlled, approved, and audited?
- What data is stored locally, and how is it erased at decommissioning?
- Can the device operate safely if cloud connectivity or internet access is lost?
- Is there a vulnerability disclosure route and a named contact for security issues?
I also want procurement to capture operational reality, not just compliance language. If a device is meant for a ward, ask how it will behave in a ward. If it is meant for a patient’s home, ask what assumptions it makes about Wi-Fi, support, and user competence. That is where many projects quietly fail, because the deployment environment is treated as an afterthought.
The baseline I would not deploy without
My minimum bar is simple: every device must have an owner, a support horizon, a segmented network path, a defined update process, and a tested response playbook. If any one of those is missing, the risk is being carried somewhere else in the organisation, usually by clinicians or support staff who did not agree to own it.
- A live inventory with model, firmware, owner, and support status.
- A hardened network zone with explicit allowed flows.
- Signed updates, rollback options, and a realistic validation workflow.
- Central logging or at least enough telemetry to spot abnormal behaviour.
- A clinical fallback plan that keeps care going during isolation or maintenance.
- A decommissioning process that removes data and closes remote access.
That is the practical meaning of IoMT security in a live clinical environment: reduce blast radius, keep treatment available, and make every handoff explicit. If you get those basics right, the more advanced controls start to matter; if you skip them, the rest is mostly decoration.
